Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company's products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Balaxi Pharmaceuticals Ltd FAQs
How to Buy Balaxi Pharmaceuticals Ltd Share?
To purchase Balaxi Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Balaxi Pharmaceuticals Ltd (ticker symbol: BALAXI) on the trading platform provided by your broker and purchase the shares.
The stock price of Balaxi Pharmaceuticals Ltd as of 18 Dec 2025 is ₹27.57
What is the Market Cap of Balaxi Pharmaceuticals Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 18 Dec 2025, Balaxi Pharmaceuticals Ltd (ticker symbol: BALAXI) has a market capitalisation of approximately ₹1,70,00,00,000.00
What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd?
Balaxi Pharmaceuticals Ltd Ltd's price-to-book ratio as of 18 Dec 2025 is 0.66, reflecting the market's valuation compared to its asset value. As of 18 Dec 2025, the trailing twelve months P/E (price-to-earnings) ratio is 10.48, indicating the market values the company at around ₹10.48 for every ₹1 of earnings
What is the 52 Week High and Low of Balaxi Pharmaceuticals Ltd Share?
Balaxi Pharmaceuticals Ltd Ltd (BALAXI) hit its 52-week high at ₹84.00, and its 52-week low at ₹27.09.